Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
for Metastatic Breast Cancer
14 locations incl. Goodyear
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06428396·Phase 2·Recruiting